Exact Mass: 506.0117

Exact Mass Matches: 506.0117

Found 31 metabolites which its exact mass value is equals to given mass value 506.0117, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cefditoren

(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C19H18N6O5S3 (506.0501)


Cefditoren is only found in individuals that have used or taken this drug. It is a third-generation cephalosporin antibiotic for oral use. It is commonly marketed under the trade name Spectracef by Cornerstone BioPharma.The bactericidal activity of cefditoren results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cefditoren is stable in the presence of a variety of b-lactamases, including penicillinases and some cephalosporinases. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Valoneaic acid

Valoneaic acid

C21H14O15 (506.0333)


   

(3R,4S,5S,6S)-6-[4-Chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(3R,4S,5S,6S)-6-[4-Chloro-2-(furan-2-ylmethylamino)-5-sulphamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C18H19ClN2O11S (506.0398)


   

Phosphoaminophosphonic acid-adenylate ester

({[({[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}amino)phosphonic acid

C10H17N6O12P3 (506.0117)


   
   

Gossypetin 7,8-dimethyl ether 3,3-disulfate

2-[4-Hydroxy-3-(sulfooxy)phenyl]-5-hydroxy-7,8-dimethoxy-3-(sulfooxy)-4H-1-benzopyran-4-one

C17H14O14S2 (505.9825)


   

Sanguisorbic acid

Sanguisorbic acid

C21H14O15 (506.0333)


   
   

Dehydrotrigallic acid

Dehydrotrigallic acid

C21H14O15 (506.0333)


   

Furosemide glucuronide

FUROSEMIDE ACYL-B-D-GLUCURONIDE

C18H19ClN2O11S (506.0398)


   

4-(Perfluorooctyl)-2-methyl-2-butanol

4-(Perfluorooctyl)-2-methyl-2-butanol

C13H11F17O (506.0538)


   
   

(S)-METHYL 2-AMINO-3-(3,5-DICHLORO-4-((2-PHENYLBENZO[D]OXAZOL-7-YL)METHOXY)PHENYL)PROPANOATE HYDROCHLORIDE

(S)-METHYL 2-AMINO-3-(3,5-DICHLORO-4-((2-PHENYLBENZO[D]OXAZOL-7-YL)METHOXY)PHENYL)PROPANOATE HYDROCHLORIDE

C24H21Cl3N2O4 (506.0567)


   

3,3-Diethyl-9-methylthiacarbocyanine iodide

3,3-Diethyl-9-methylthiacarbocyanine iodide

C22H23IN2S2 (506.0347)


   

Lead,bis(N,N-diethylcarbamodithioato-kS,kS)-, (T-4)-

Lead,bis(N,N-diethylcarbamodithioato-kS,kS)-, (T-4)-

C10H22N2PbS4 (506.0432)


   

Phosphoaminophosphonic acid-adenylate ester

Phosphoaminophosphonic acid-adenylate ester

C10H17N6O12P3 (506.0117)


COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   

2-Amino-2-deoxyadenosine 5-(tetrahydrogen triphosphate)

2-Amino-2-deoxyadenosine 5-(tetrahydrogen triphosphate)

C10H17N6O12P3 (506.0117)


   

(2S,3S,4S,5R)-6-[4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R)-6-[4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C18H19ClN2O11S (506.0398)


   

9-{5-O-[(R)-Hydroxy{[(R)-Hydroxy(Phosphonoamino)phosphoryl]oxy}phosphoryl]-Alpha-L-Arabinofuranosyl}-9h-Purin-6-Amine

9-{5-O-[(R)-Hydroxy{[(R)-Hydroxy(Phosphonoamino)phosphoryl]oxy}phosphoryl]-Alpha-L-Arabinofuranosyl}-9h-Purin-6-Amine

C10H17N6O12P3 (506.0117)


   

(3R,4S,5S,6S)-6-[4-Chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

(3R,4S,5S,6S)-6-[4-Chloro-2-(furan-2-ylmethylamino)-5-sulphamoylbenzoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C18H19ClN2O11S (506.0398)


   
   

[[(2R,3R,4S,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxypyrrolidin-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

[[(2R,3R,4S,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxypyrrolidin-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate

C10H17N6O12P3 (506.0117)


   

[3-bromo-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]-(3,4-dihydro-2H-quinolin-1-yl)methanone

[3-bromo-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]-(3,4-dihydro-2H-quinolin-1-yl)methanone

C21H14BrF3N4OS (506.0024)


   

2-[[5-(5-bromo-2-benzofuranyl)-4-methyl-1,2,4-triazol-3-yl]thio]-N-(5-chloro-2-methoxyphenyl)acetamide

2-[[5-(5-bromo-2-benzofuranyl)-4-methyl-1,2,4-triazol-3-yl]thio]-N-(5-chloro-2-methoxyphenyl)acetamide

C20H16BrClN4O3S (505.9815)


   

Cefditoren

Cefditoren

C19H18N6O5S3 (506.0501)


A broad spectrum, third-generation cephalosporin antibiotic with (Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. Generally administered as its orally absorbed pivaloyloxymethyl ester prodrug, it is used for the treatment of mild to moderate infections caused by susceptible strains of microorganisms in acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Valoneaic acid

Valoneaic acid

C21H14O15 (506.0333)


   
   

3,3'-bis(2-aminoethyl)-5,5'-dibromo-1h,1'h-[4,4'-biindole]-7,7'-diol

3,3'-bis(2-aminoethyl)-5,5'-dibromo-1h,1'h-[4,4'-biindole]-7,7'-diol

C20H20Br2N4O2 (505.9953)


   

5-(6-carboxy-2,3,4-trihydroxyphenoxy)-2-(5-carboxy-2,3-dihydroxyphenoxy)-3,4-dihydroxybenzoic acid

5-(6-carboxy-2,3,4-trihydroxyphenoxy)-2-(5-carboxy-2,3-dihydroxyphenoxy)-3,4-dihydroxybenzoic acid

C21H14O15 (506.0333)


   

{5-hydroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]-7,8-dimethoxy-4-oxochromen-3-yl}oxidanesulfonic acid

{5-hydroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]-7,8-dimethoxy-4-oxochromen-3-yl}oxidanesulfonic acid

C17H14O14S2 (505.9825)